Adelaide Research & Scholarship: Search

Search

Results 1-10 of 18 (Search time: 0.003 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2007	Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadon	Coller, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
	2004	Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre	Jittiwutikarn, J.; Ali, R.; White, J.; Bochner, F.; Somogyi, A.; Foster, D.
	1997	Methadone-related overdose deaths in South Australia, 1984-1994. How safe is methadone prescribing?	Williamson, P.; Foreman, K.; White, J.; Anderson, G.
	2005	Short-term outcomes of five heroin detoxification methods in the Australian NEPOD project	Digiusto, E.; Lintzeris, N.; Breen, C.; Kimber, J.; Mattick, R.; Bell, J.; Ali, R.; Saunders, J.
	2005	Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects	Hanna, J.; Foster, D.; Salter, A.; Somogyi, A.; White, J.; Bochner, F.
	1999	Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.	Foster, D.; Somogyi, A.; Bochner, F.
	2005	The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)	Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
	2009	The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratio	Bell, J.; Shearer, J.; Ryan, A.; Graham, R.; Korompay, K.; Rizzo, S.; Sindhusake, D.; Somogyi, A.
	1999	Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships	Dyer, K.; Foster, D.; White, J.; Somogyi, A.; Menelaou, A.; Bochner, F.
	2008	Antinociceptive effects of high dose remifentanil in male methadone-maintained patients	Hay, J.; White, J.; Bochner, F.; Somogyi, A.